Anthranilic amide and imidazobenzothiadiazole compounds disrupt


Journal

MedChemComm
ISSN: 2040-2511
Titre abrégé: Medchemcomm
Pays: England
ID NLM: 101531525

Informations de publication

Date de publication:
01 Jun 2019
Historique:
received: 09 02 2019
accepted: 12 04 2019
entrez: 16 7 2019
pubmed: 16 7 2019
medline: 16 7 2019
Statut: epublish

Résumé

A family of compounds typified by an anthranilic amide

Identifiants

pubmed: 31303991
doi: 10.1039/c9md00088g
pii: c9md00088g
pmc: PMC6596218
doi:

Types de publication

Journal Article

Langues

eng

Pagination

934-945

Références

J Bacteriol. 1999 Apr;181(7):2044-9
pubmed: 10094680
J Biomol Screen. 2002 Aug;7(4):383-9
pubmed: 12230893
J Antimicrob Chemother. 2003 Jul;52(1):56-60
pubmed: 12775670
Biochemistry. 1963 Mar-Apr;2:357-61
pubmed: 13954345
J Antimicrob Chemother. 2003 Nov;52(5):790-5
pubmed: 14563891
Science. 2003 Oct 24;302(5645):654-9
pubmed: 14576437
Front Biosci. 2004 May 01;9:1059-72
pubmed: 14977529
Bioorg Med Chem Lett. 2004 Jun 7;14(11):2823-7
pubmed: 15125940
Bioorg Med Chem. 2006 Aug 15;14(16):5562-77
pubmed: 16697646
J Med Chem. 2006 Oct 19;49(21):6371-90
pubmed: 17034143
Bioorg Med Chem. 2007 Nov 15;15(22):6994-7011
pubmed: 17851084
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6905-9
pubmed: 18029172
Bioorg Med Chem. 2008 Apr 1;16(7):3917-25
pubmed: 18289861
Nat Med. 2008 Aug;14(8):849-54
pubmed: 18641659
Tuberculosis (Edinb). 2008 Aug;88 Suppl 1:S25-33
pubmed: 18762150
Bioorg Med Chem Lett. 2009 Nov 15;19(22):6373-5
pubmed: 19811913
PLoS One. 2010 May 24;5(5):e10777
pubmed: 20520722
Nature. 2011 Jan 27;469(7331):483-90
pubmed: 21270886
ACS Med Chem Lett. 2011;2(11):849-854
pubmed: 22096616
J Antimicrob Chemother. 2012 Feb;67(2):404-14
pubmed: 22101217
Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6554-9
pubmed: 23576728
PLoS One. 2013 Apr 04;8(4):e60531
pubmed: 23593234
Molecules. 2013 Jun 10;18(6):6883-97
pubmed: 23752471
PLoS One. 2013 Jul 30;8(7):e68942
pubmed: 23935911
ChemMedChem. 2015 Jan;10(1):57-61
pubmed: 25209672
Lancet Respir Med. 2017 Mar 15;:null
pubmed: 28344011
Bioorg Med Chem. 2017 Aug 1;25(15):3922-3946
pubmed: 28576632
Lancet Infect Dis. 2018 Mar;18(3):261-284
pubmed: 29223583
ACS Infect Dis. 2019 Feb 8;5(2):272-280
pubmed: 30501173
Science. 1994 Feb 4;263(5147):678-81
pubmed: 8303277
J Cell Sci. 1998 Apr;111 ( Pt 7):897-905
pubmed: 9490634
J Immunol. 1998 Feb 1;160(3):1290-6
pubmed: 9570546

Auteurs

Jake Smith (J)

TB Discovery Research , Infectious Disease Research Institute , 1616 Eastlake Ave E, Suite 400 , Seattle , Washington 98102 , USA . Email: tanya.parish@idri.org.

Heather Wescott (H)

TB Discovery Research , Infectious Disease Research Institute , 1616 Eastlake Ave E, Suite 400 , Seattle , Washington 98102 , USA . Email: tanya.parish@idri.org.

Julie Early (J)

TB Discovery Research , Infectious Disease Research Institute , 1616 Eastlake Ave E, Suite 400 , Seattle , Washington 98102 , USA . Email: tanya.parish@idri.org.

Steven Mullen (S)

TB Discovery Research , Infectious Disease Research Institute , 1616 Eastlake Ave E, Suite 400 , Seattle , Washington 98102 , USA . Email: tanya.parish@idri.org.

Junitta Guzman (J)

TB Discovery Research , Infectious Disease Research Institute , 1616 Eastlake Ave E, Suite 400 , Seattle , Washington 98102 , USA . Email: tanya.parish@idri.org.

Joshua Odingo (J)

TB Discovery Research , Infectious Disease Research Institute , 1616 Eastlake Ave E, Suite 400 , Seattle , Washington 98102 , USA . Email: tanya.parish@idri.org.

Jason Lamar (J)

Lilly Research Laboratories , Eli Lilly and Company , 307 E Merrill St , Indianapolis , Indiana 46285 , USA.

Tanya Parish (T)

TB Discovery Research , Infectious Disease Research Institute , 1616 Eastlake Ave E, Suite 400 , Seattle , Washington 98102 , USA . Email: tanya.parish@idri.org.

Classifications MeSH